Choice's broking arm receives ₹900 Cr from NH Investment & Securities, closing the CCPS deal signed in July

The mechanics, as the filings state them: the CCPS are cumulative and compulsorily convertible into CEBPL equity shares per the terms of the Definitive Agreements, and the equity shares allotted on conversion will rank pari passu with CEBPL's existing equity. What the filings do not disclose is the conversion ratio or timeline, NHIS's resulting stake in CEBPL, or the implied valuation of the broking subsidiary — so none of those can be stated here. What can be sized: at ₹899.99 crore, the infusion into the subsidiary equals roughly 5.6% of Choice International's own market capitalisation of about ₹16,065 crore (22.28 crore shares at the ₹721.15 close).

The counterparty's scale matters to the read. Per the Regulation 30 filing, NHIS operates over 57 domestic branches and offices plus 8 overseas operations, serving retail, corporate and institutional clients. For a parent that, by its own press release, serves over 1.6 million clients through 70,000+ business associates, a foreign institution of that size subscribing ₹900 crore into the broking arm — at a premium of ₹2,120 over a ₹10 face value — is third-party capital validation at the subsidiary level, which is where Choice earns most of its consolidated revenue (standalone Q1 FY27 revenue was ₹11.54 crore against ₹309.79 crore consolidated).

The stock closed Tuesday at ₹721.15, up 3.3% from Monday's ₹698.05 on 11.58 lakh shares — the heaviest session since July 31. But both filings reached the exchange after 17:00 IST, well past the 15:30 close, so Tuesday's move preceded the announcement and cannot be read as a reaction to it; the first session that can price the closing is the next one. The broader tape has been soft: from ₹822.95 at end-July the stock drifted to a ₹684.95 close on October 23 before recovering over the last two sessions, and it sits 16.2% below its 52-week adjusted high of ₹860.5 set on January 5. One caveat worth repeating from the filings' own sequence: the transaction itself was announced on July 9, so whatever the deal is worth to the stock has had three and a half months to be absorbed — what is new information is that the approvals came through and the cash arrived.

Q1 FY27 consolidated revenue of ₹309.79 crore was up 32.5% over the ₹233.88 crore of Q1 FY26, with net profit of ₹60.61 crore up 26.4% over ₹47.96 crore, at a 33.8% operating margin and EPS of ₹2.72. Net profit was sequentially lower than Q4 FY26's ₹67.84 crore. The standalone numbers underline why the subsidiary-level raise is the one that matters: the listed parent's own Q1 FY27 revenue was ₹11.54 crore — the operating business lives in the subsidiaries. On ownership, the promoter stake held at 53.65% across the March and June 2026 shareholding patterns, while FII holdings slipped from 2.54 crore shares (11.4% of total) to 2.25 crore shares (10.1%) over the same two quarters, per the pattern.